rs2039531

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001365999.1(SZT2):​c.6034+11A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.376 in 1,612,742 control chromosomes in the GnomAD database, including 121,820 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.31 ( 8608 hom., cov: 33)
Exomes 𝑓: 0.38 ( 113212 hom. )

Consequence

SZT2
NM_001365999.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.166

Publications

10 publications found
Variant links:
Genes affected
SZT2 (HGNC:29040): (SZT2 subunit of KICSTOR complex) The protein encoded by this gene is expressed in the brain, predominantly in the parietal and frontal cortex as well as in dorsal root ganglia. It is localized to the peroxisome, and is implicated in resistance to oxidative stress. It likely functions by increasing superoxide dismutase (SOD) activity, but itself has no direct SOD activity. Studies in mice show that this gene confers low seizure threshold, and may also enhance epileptogenesis. [provided by RefSeq, Jun 2011]
SZT2 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 18
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 1-43435340-A-C is Benign according to our data. Variant chr1-43435340-A-C is described in ClinVar as Benign. ClinVar VariationId is 260619.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.404 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SZT2NM_001365999.1 linkc.6034+11A>C intron_variant Intron 42 of 71 ENST00000634258.3 NP_001352928.1
SZT2NM_015284.4 linkc.5863+11A>C intron_variant Intron 41 of 70 NP_056099.3 Q5T011-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SZT2ENST00000634258.3 linkc.6034+11A>C intron_variant Intron 42 of 71 5 NM_001365999.1 ENSP00000489255.1 Q5T011-1
SZT2ENST00000562955.2 linkc.5863+11A>C intron_variant Intron 41 of 70 5 ENSP00000457168.1 Q5T011-5
SZT2ENST00000648058.1 linkn.2488+11A>C intron_variant Intron 10 of 39
SZT2ENST00000649403.1 linkn.784+11A>C intron_variant Intron 7 of 36

Frequencies

GnomAD3 genomes
AF:
0.312
AC:
47397
AN:
151930
Hom.:
8610
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.142
Gnomad AMI
AF:
0.423
Gnomad AMR
AF:
0.381
Gnomad ASJ
AF:
0.426
Gnomad EAS
AF:
0.0743
Gnomad SAS
AF:
0.145
Gnomad FIN
AF:
0.391
Gnomad MID
AF:
0.434
Gnomad NFE
AF:
0.408
Gnomad OTH
AF:
0.371
GnomAD2 exomes
AF:
0.325
AC:
81260
AN:
249812
AF XY:
0.325
show subpopulations
Gnomad AFR exome
AF:
0.134
Gnomad AMR exome
AF:
0.324
Gnomad ASJ exome
AF:
0.436
Gnomad EAS exome
AF:
0.0669
Gnomad FIN exome
AF:
0.400
Gnomad NFE exome
AF:
0.415
Gnomad OTH exome
AF:
0.370
GnomAD4 exome
AF:
0.383
AC:
558898
AN:
1460694
Hom.:
113212
Cov.:
36
AF XY:
0.377
AC XY:
273944
AN XY:
726630
show subpopulations
African (AFR)
AF:
0.138
AC:
4628
AN:
33466
American (AMR)
AF:
0.334
AC:
14889
AN:
44642
Ashkenazi Jewish (ASJ)
AF:
0.433
AC:
11313
AN:
26126
East Asian (EAS)
AF:
0.100
AC:
3988
AN:
39684
South Asian (SAS)
AF:
0.158
AC:
13590
AN:
86200
European-Finnish (FIN)
AF:
0.392
AC:
20825
AN:
53080
Middle Eastern (MID)
AF:
0.395
AC:
2271
AN:
5756
European-Non Finnish (NFE)
AF:
0.419
AC:
465661
AN:
1111378
Other (OTH)
AF:
0.360
AC:
21733
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
17092
34183
51275
68366
85458
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13976
27952
41928
55904
69880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.312
AC:
47415
AN:
152048
Hom.:
8608
Cov.:
33
AF XY:
0.308
AC XY:
22878
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.142
AC:
5897
AN:
41474
American (AMR)
AF:
0.381
AC:
5823
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.426
AC:
1475
AN:
3466
East Asian (EAS)
AF:
0.0743
AC:
384
AN:
5170
South Asian (SAS)
AF:
0.147
AC:
707
AN:
4818
European-Finnish (FIN)
AF:
0.391
AC:
4135
AN:
10564
Middle Eastern (MID)
AF:
0.442
AC:
130
AN:
294
European-Non Finnish (NFE)
AF:
0.408
AC:
27703
AN:
67962
Other (OTH)
AF:
0.369
AC:
777
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1618
3236
4855
6473
8091
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.298
Hom.:
1380
Bravo
AF:
0.307
Asia WGS
AF:
0.129
AC:
448
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 18 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
9.1
DANN
Benign
0.63
PhyloP100
0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2039531; hg19: chr1-43901011; COSMIC: COSV65170599; COSMIC: COSV65170599; API